ONCOLYTICS BIOTECH INC

Yahoo! Finance: ONC.TO NewsLatest Financial News for ONCOLYTICS BIO

URL

XML feed
http://finance.yahoo.com/q/h?s=onc.to

Last update

5 min 39 sec ago

July 29, 2010

05:30
Oncolytics Biotech(R) Inc. Announces Second Quarter 2010 Results (CNW Group)

July 28, 2010

02:15
Oncolytics Biotech(R) Inc. Receives Approval from Belgium FAMHP to Conduct Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers (CNW Group)
02:15
Oncolytics Biotech(R) Inc. Announces Publication of Phase I Clinical Trial Results in Clinical Cancer Research (CNW Group)

July 21, 2010

23:19
Oncolytics Biotech(R) Inc. Announces First Quarter 2010 Results (CNW Group)
22:04
Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Pancreatic Cancer Clinical Trial (CNW Group)

July 20, 2010

22:13
Oncolytics opens enrollment of cancer drug trial (AP)
Canadian drug developer Oncolytics Biotech Inc. said Tuesday it has opened enrollment for a late-stage trial of the cancer treatment candidate Reolysin.
19:25
Oncolytics Biotech(R) Inc. Announces Opening of Enrollment in Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers (CNW Group)

July 19, 2010

17:44
Oncolytics Biotech(R) Inc. Collaborators Present Positive Updated U.K. Phase I/II Trial Results in Advanced Solid Cancers with a Focus on the Head and Neck at the ASCO Annual Meeting (CNW Group)
07:20
CANADA STOCKS-TSX may open lower on weaker commodity prices (at Reuters)
07:20
UPDATE - Health Canada OKs cancer drug trial plan: Oncolytics (at Reuters)
06:14
Oncolytics Biotech(R) Inc. Receives No Objection Letter from Health Canada to Conduct Phase 3 Trial of REOLYSIN(R) in Head and Neck Cancers (CNW Group)

July 17, 2010

00:07
Oncolytics Biotech(R) Inc. Completes Patient Enrollment in Phase I Portion of U.S. Phase I/II Recurrent Malignant Gliomas Clinical Trial (CNW Group)